CSR Synopses following approval of a new medicine or a new indication for an approved medicine in the US or EU. We are making CSR synopses available to supplement the public information available to patients and healthcare providers about the results of our clinical trials and the evidence used to approve a new medicine or a new indication.
|3001077||Acutely decompensated heart failure||CSR.ORG||Survival of Patients with Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomise…|
|3001069||Acutely decompensated heart failure||CSR.ORG||Randomized, Multicenter Evaluation of Intravenous LeVosimendan Efficacy Versus Placebo in the Short Term Treatment of Decompens…|
No results found